Cornerstone Planning Group
ANIP icon

Cornerstone Planning Group’s ANI Pharmaceuticals ANIP Stock Holding History

Cornerstone Planning Group’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-9
Closed -$698 – 254
2026
Q2 		$698 Hold
9
– – ﹤0.01% 1595
2026
Q1 		$762 Hold
9
– – ﹤0.01% 1535
2025
Q4 		$716 Hold
9
– – ﹤0.01% 1429
2025
Q3 		$827 Hold
9
– – ﹤0.01% 1361
2025
Q2 		$593 Hold
9
– – ﹤0.01% 1248
2025
Q1 		$615 Hold
9
– – ﹤0.01% 1238
2024
Q4 		$544 Buy
+9
New +$517 ﹤0.01% 1109

Other funds holding ANIP

Oliver Luxxe Assets
Oliver Luxxe Assets Gladstone, New Jersey $638M AUM 30.27% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wedge Capital Management
Wedge Capital Management Charlotte, North Carolina $5.72B AUM 38.26% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
Louisiana State Employees Retirement System
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.56B AUM 41.43% 1-Year Est. Return
Kings Path Partners
Kings Path Partners Sugar Land, Texas $380M AUM 12.42% 1-Year Est. Return
State of Alaska Department of Revenue
State of Alaska Department of Revenue Juneau, Alaska $9.6B AUM 34.67% 1-Year Est. Return
Quadrant Capital Group
Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Cornerstone Planning Group's ANIP Position: Q3 2026 in Review

Cornerstone Planning Group sold out of ANI Pharmaceuticals (ANIP) in Q3 2026, closing a stake of 9 shares — an estimated $698 sold.

Cornerstone Planning Group first reported a position in ANIP in Q4 2024 and held it in 7 quarters. The position peaked at $827 in Q3 2025. 26 funds tracked by Wall St. Rank hold ANIP as of Q3 2026.

  • Cornerstone Planning Group reported no remaining ANI Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Cornerstone Planning Group sold 9 ANI Pharmaceuticals shares in Q3 2026, an estimated $698.
  • Cornerstone Planning Group first reported a position in ANI Pharmaceuticals in Q4 2024 and held it in 7 quarters.
  • Cornerstone Planning Group's ANI Pharmaceuticals position peaked at $827 in Q3 2025.
  • 26 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2026.

Based on Cornerstone Planning Group's 13F filing for Q3 2026, filed 16 Oct 2026.